Translational research

Translational research projects encourage collaborations between basic and clinical research. Their goal is to study cells and their interactions with the environment, and in so doing to provide new impulses for novel therapies and clinical approaches in order to be able to act on the causes of cellular malfunction.  

Financial support for translational cancer research projects is possible thanks to:

"Allocated funds" - These funds are specifically created for each project. They come from private donations and must be used for the predetermined purpose. The Foundation guarantees that donations are used in full to finance the project to which they have been allocated.

“ISREC chairs” - These are created to offer young professors affiliated to the EPFL (School of Life Sciences - ISREC) or to a Swiss University (Faculty of biology or medicine) the opportunity to launch their career in research. They are financed by the fortune of the Foundation.

Translational research - ongoing projects

Flash Radiotherapy

This “allocated fund” from the Biltema Foundation was allocated in July 2016 for three years.

Research laboratories of Prof. George Coukos...

More information

Personalized immunotherapy

This “allocated fund” from the Biltema Foundation was allocated in July 2016 for three years.

Research laboratories of Prof. George Coukos...

More information

Development of antibody therapies for tumors and breast cancer

This “allocated fund” from the Biltema Foundation was allocated in July 2016 for three years.

Research laboratories of Prof. Carl Borrebaeck (LUND)

More information

News & Events

Posted on

The ISREC Foundation has the honor to present its AGORA – Cancer Center project during the Lausanne Tourism «Lausanne, international academic and...

Read more
Posted on

Congratulations to Prof. Laurence Zitvogel, whose work is supported by the ISREC Foundation, and to Guido Kroemer who have won the Brupbacher Cancer...

Read more
Posted on

Congratulations to Bojan Bujisic, one of our UNIL « PhD Programm » grant recipients, for his publication in Blood Journal.

Read more
Posted on

Congratulations to Prof. Oliver Hantschel, supported by the ISREC Foundation. He works on an extensive study in the cause of leukemia that could...

Read more